Anthracycline cardiotoxicity in patients receiving sodium-glucose co-transporter-2 inhibitors -is there any difference?

被引：0
|
作者：
Stratinaki, M. [1 ]
Maragkoudakis, S. [2 ]
Georgopoulou, T. [1 ]
Aletras, G. [1 ]
Eleftheriadou, E. [1 ]
Korela, D. [1 ]
Stavrakis, S. [1 ]
Honda, E. [1 ]
Pitarokoilis, M. [1 ]
Lambrogiannakis, E. [1 ]
Garidas, G. [1 ]
Liapi, D. [3 ]
Detoraki, M. [1 ]
Kafkala, K. [2 ]
Foukarakis, E. [1 ]
机构：
[1] Venizelio Gen Hosp, Dept Cardiol, Iraklion, Greece
[2] Gen Hosp St George, Cardiol, Khania, Greece
[3] Venizelio Gen Hosp, Dept Hematol, Iraklion, Greece
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：574 / 574
页数：1
相关论文
共 50 条
  • [1] Sodium-glucose co-transporter-2 inhibitors for type 1 diabetes: Not any more?
    Czupryniak, Leszek
    Danne, Thomas
    Szymanska-Garbacz, Elektra
    Zozulinska-Ziolkiewicz, Dorota
    Gumprecht, Janusz
    Klupa, Tomasz
    DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 764 - 765
  • [2] Is there any place for sodium-glucose co-transporter-2 inhibitors in post-liver transplantation patients?
    Patoulias, Dimitrios
    Katsimardou, Alexandra
    Kalogirou, Maria-Styliani
    Karagiannis, Asterios
    Doumas, Michael
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (02) : 239 - 240
  • [3] Sodium-glucose co-transporter-2 inhibitors and epicardial adiposity
    Yaribeygi, Habib
    Maleki, Mina
    Butler, Alexandra E.
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 180
  • [4] A review of the safety of sodium-glucose co-transporter-2 inhibitors
    O'Hara, Daniel Vincent
    Jardine, Meg J.
    DIABETES OBESITY & METABOLISM, 2025,
  • [5] REPURPOSING SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS FOR GEROTHERAPY
    Espinoza, Sara
    INNOVATION IN AGING, 2024, 8 : 140 - 140
  • [6] Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors
    Perelman, Moran Gvili
    Brzezinski, Rafael Y.
    Waissengrin, Barliz
    Leshem, Yasmin
    Bainhoren, Or
    Rubinstein, Tammi Arbel
    Perelman, Maxim
    Rozenbaum, Zach
    Havakuk, Ofer
    Topilsky, Yan
    Banai, Shmuel
    Wolf, Ido
    Laufer-Perl, Michal
    CARDIO-ONCOLOGY, 2024, 10 (01)
  • [7] Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors
    Moran Gvili Perelman
    Rafael Y. Brzezinski
    Barliz Waissengrin
    Yasmin Leshem
    Or Bainhoren
    Tammi Arbel Rubinstein
    Maxim Perelman
    Zach Rozenbaum
    Ofer Havakuk
    Yan Topilsky
    Shmuel Banai
    Ido Wolf
    Michal Laufer-Perl
    Cardio-Oncology, 10
  • [8] The Evolution of Sodium-Glucose Co-Transporter-2 Inhibitors in Heart Failure
    Fadiran, Olusayo
    Nwabuo, Chike
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [9] Sodium-glucose co-transporter-2 inhibitors : a potential cardioprotective agent?
    Stratinaki, M.
    Maragkoudakis, S.
    Stavrakis, S.
    Papoutsaki, E.
    Korela, D.
    Aletras, G.
    Honda, E.
    Garidas, G.
    Georgopoulou, T.
    Eleftheriadou, E.
    Pitarokoilis, M.
    Liapi, D.
    Kafkala, K.
    Foukarakis, E.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [10] Sodium-glucose co-transporter-2 inhibitors and the risk of fractures in patients with type 2 diabetes
    Schmedt, Niklas
    Andersohn, Frank
    Walker, Jochen
    Garbe, Edeltraut
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 454 - 454
12345